These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21871597)

  • 1. Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.
    Wu XX; Guller S; Rand JH
    Am J Obstet Gynecol; 2011 Dec; 205(6):576.e7-14. PubMed ID: 21871597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.
    Rand JH; Wu XX; Quinn AS; Ashton AW; Chen PP; Hathcock JJ; Andree HA; Taatjes DJ
    Blood; 2010 Mar; 115(11):2292-9. PubMed ID: 19965621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.
    Rand JH; Wu XX; Guller S; Scher J; Andree HA; Lockwood CJ
    Am J Obstet Gynecol; 1997 Oct; 177(4):918-23. PubMed ID: 9369845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.
    Rand JH; Wu XX; Andree HA; Lockwood CJ; Guller S; Scher J; Harpel PC
    N Engl J Med; 1997 Jul; 337(3):154-60. PubMed ID: 9219701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.
    Rand JH; Wu XX; Quinn AS; Chen PP; McCrae KR; Bovill EG; Taatjes DJ
    Am J Pathol; 2003 Sep; 163(3):1193-200. PubMed ID: 12937161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion.
    Rand JH; Wu XX; Guller S; Gil J; Guha A; Scher J; Lockwood CJ
    Am J Obstet Gynecol; 1994 Dec; 171(6):1566-72. PubMed ID: 7802069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.
    Rand JH; Wu XX; Quinn AS; Taatjes DJ
    Lupus; 2010 Apr; 19(4):460-9. PubMed ID: 20353989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome.
    Hunt BJ; Wu XX; de Laat B; Arslan AA; Stuart-Smith S; Rand JH
    Am J Obstet Gynecol; 2011 Nov; 205(5):485.e17-23. PubMed ID: 21784397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiphospholipid antibodies and recurrent abortions: possible pathogenetic role of annexin A5 investigated by confocal microscopy].
    Peluso G; Morrone G
    Minerva Ginecol; 2007 Jun; 59(3):223-9. PubMed ID: 17576401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of atomic force microscopy to study the pathologic effects of anti-annexin autoantibodies.
    Irman S; Skarabot M; Muševič I; Rozman B; Božič B
    J Autoimmun; 2011 Mar; 36(2):98-105. PubMed ID: 21185149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.
    Rand JH; Wu XX; Quinn AS; Chen PP; Hathcock JJ; Taatjes DJ
    Blood; 2008 Sep; 112(5):1687-95. PubMed ID: 18577708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated interference with annexins in the antiphospholipid syndrome.
    Rand JH; Wu XX
    Thromb Res; 2004; 114(5-6):383-9. PubMed ID: 15507268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function.
    Albert CR; Schlesinger WJ; Viall CA; Mulla MJ; Brosens JJ; Chamley LW; Abrahams VM
    Am J Reprod Immunol; 2014 Feb; 71(2):154-64. PubMed ID: 24325143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new trick for an ancient drug: quinine dissociates antiphospholipid immune complexes.
    Bezati E; Wu XX; Quinn AS; Taatjes DJ; Rand JH
    Lupus; 2015 Jan; 24(1):32-41. PubMed ID: 25139939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies.
    Marchetti T; Ruffatti A; Wuillemin C; de Moerloose P; Cohen M
    J Thromb Haemost; 2014 Jun; 12(6):910-20. PubMed ID: 24656088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible solution to the paradox of the "lupus anticoagulant": antiphospholipid antibodies accelerate thrombin generation by inhibiting annexin-V.
    Rand JH; Wu XX; Giesen P
    Thromb Haemost; 1999 Oct; 82(4):1376-7. PubMed ID: 10544942
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome.
    Rand JH
    J Autoimmun; 2000 Sep; 15(2):107-11. PubMed ID: 10968894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon.
    Rand JH; Wu XX; Andree HA; Ross JB; Rusinova E; Gascon-Lema MG; Calandri C; Harpel PC
    Blood; 1998 Sep; 92(5):1652-60. PubMed ID: 9716593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibody syndrome: new insights on thrombogenic mechanisms.
    Rand JH
    Am J Med Sci; 1998 Aug; 316(2):142-51. PubMed ID: 9704667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibodies, annexin V, and pregnancy loss.
    Rote NS
    N Engl J Med; 1997 Nov; 337(22):1630; author reply 1631. PubMed ID: 9411224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.